Home/Filings/4/0001178913-25-000157
4//SEC Filing

Malca Yonatan 4

Accession 0001178913-25-000157

CIK 0001638097other

Filed

Jan 16, 7:00 PM ET

Accepted

Jan 17, 4:31 PM ET

Size

7.5 KB

Accession

0001178913-25-000157

Insider Transaction Report

Form 4
Period: 2025-01-15
Transactions
  • Award

    Stock Option (right to buy)

    2025-01-15+28,50928,509 total
    Exercise: $2.28Exp: 2035-01-15Ordinary Shares, par value NIS 0.0000769 per share (28,509 underlying)
  • Award

    Ordinary Shares, par value NIS 0.0000769 per share

    2025-01-15+8,21647,259 total
Footnotes (2)
  • [F1]The Board of Directors ("Board") of Entera Bio Ltd. (the "Company") awarded these shares to the Reporting Persons in lieu of the cash fees the Reported Person was entitled to for services rendered as a director of the Company for the fourth quarter of 2024.
  • [F2]These options represent the Board's annual grant of options to directors of the Company. The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2025.

Documents

1 file

Issuer

Entera Bio Ltd.

CIK 0001638097

Entity typeother

Related Parties

1
  • filerCIK 0001904759

Filing Metadata

Form type
4
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:31 PM ET
Size
7.5 KB